1-5 of 5
Onyee Chan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1 -mutated AML

Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew Kuykendall, Eric Padron, Alison Walker, Gail Roboz, Pinkal Desai, David Sallman, Kendra Sweet, Rami Komrokji, Jeffrey Lancet
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1075–1083.
https://doi.org/10.1182/bloodadvances.2023011173
Published: 2024
Journal Articles

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

Clinical Trials & Observations
Rami S. Komrokji, Luis E. Aguirre, Najla H. Al Ali, Onyee Chan, Zhuoer Xie, Andrew Kuykendall, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David A. Sallman
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3677–3679.
https://doi.org/10.1182/bloodadvances.2023009781
Published: 2023
Journal Articles

Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes

Clinical Trials & Observations
Anthony M. Hunter, Rami S. Komrokji, Seongseok Yun, Najla Al Ali, Onyee Chan, Jinming Song, Mohammad Hussaini, Chetasi Talati, Kendra L. Sweet, Jeffrey E. Lancet, Eric Padron, Alan F. List, David A. Sallman
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1017–1028.
https://doi.org/10.1182/bloodadvances.2020003508
Published: 2021
Includes: Supplemental data
Journal Articles

Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant

Clinical Trials & Observations
Seongseok Yun, Onyee Chan, Daniel Kerr, Nicole D. Vincelette, Afshan Idrees, Qianxing Mo, Kendra Sweet, Jeffrey E. Lancet, Mohamed A. Kharfan-Dabaja, Ling Zhang, Lubomir Sokol
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3435–3442.
https://doi.org/10.1182/bloodadvances.2020001875
Published: 2020
Includes: Supplemental data
Journal Articles

Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

Clinical Trials & Observations
Onyee Chan, Chetasi Talati, Leidy Isenalumhe, Samantha Shams, Lisa Nodzon, Michael Fradley, Kendra Sweet, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv (2020) 4 (3): 530–538.
https://doi.org/10.1182/bloodadvances.2019000268
Published: 2020